NCT02481765View on ClinicalTrials.gov

Feasibility and Dose Tolerability of HD-tDCS in Healthy Adults and Children With Down Syndrome

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 15, 2015

Primary Completion Date

May 20, 2016

Study Completion Date

May 20, 2016

Conditions
Down Syndrome
Interventions
DEVICE

High definition transcranial direct current stimulation

Trial Locations (1)

53705

Department of Neurology, University of Wisconsin Madison, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT02481765 - Feasibility and Dose Tolerability of HD-tDCS in Healthy Adults and Children With Down Syndrome | Biotech Hunter | Biotech Hunter